Trial · NCT07075965
Calcium Channel Blocker in Myotonic Dystrophy Type 1
NCT07075965, Phase 1, Not yet recruiting, University of Rochester
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Calcium Channel Blocker in Myotonic Dystrophy Type 1. Trials, record NCT07075965. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07075965
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Calcium Channel Blocker in Myotonic Dystrophy Type 1
- NCT number
- NCT07075965
- Status
- Not yet recruiting
- Phases
- Phase 1
- Enrollment
- 20 participants, estimated
- Lead sponsor
- University of Rochester
- Conditions
- Myotonic Dystrophy 1
- Interventions
- Amlodipine
- First posted
- 2025-07-20
- Last updated
- 2026-11-09
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Subjects Who Provided Informed Consent | Baseline | The total number of participants who signed the informed consent document and were enrolled in the study. |
| Primary | Number of Completed Study Visits | Baseline to End of Study at week 10 | The total number of completed study visits, averaged across all enrolled participants. A visit is considered completed if all required procedures for that visit were performed. |
| Primary | Number of Subjects Who Completed the Study Without Drug Discontinuation | Baseline to End of Study at week 10 | Number of participants who completed all study visits and remained on study drug throughout the study period without permanent discontinuation due to adverse events, withdrawal, or protocol deviations. |
| Primary | Number of Subjects Who Completed the Study | Baseline to End of Study at week 10 | Number of participants who completed all required study visits and procedures through the final study visit. |
| Secondary | Mean Change in Systolic Blood Pressure | Baseline to End of Study at week 10 | Systolic blood pressure (SBP) will be measured using a standardized automated sphygmomanometer in a seated position after 5 minutes of rest. The mean change will be calculated as the difference between SBP at the final study visit and baseline |
| Secondary | Number of Participants With Non-Serious Adverse Events | Baseline to End of Study at week 10 | Number of participants who experienced at least one non-serious adverse event, as determined by investigator assessment and participant report. Events will be recorded according to MedDRA coding guidelines. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07075965
GET https://conductscience.org/api/trials/v1/NCT07075965/registered